S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app

GSK (GSK) Stock Forecast & Price Target

GBX 1,644.80
-15.20 (-0.92%)
(As of 05:37 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability

GSK Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 7 Analyst Ratings

Analysts' Consensus Price Target

GBX 1,650
High ForecastGBX 2,000
Average ForecastGBX 1,650
Low ForecastGBX 1,300
TypeCurrent Forecast
2/12/23 to 2/12/24		1 Month Ago
1/13/23 to 1/13/24		3 Months Ago
11/14/22 to 11/14/23		1 Year Ago
2/12/22 to 2/12/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
2 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetGBX 1,650GBX 1,566.36GBX 1,573.64GBX 1,541.11
Get GSK Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


GSK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GSK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GSK Stock vs. The Competition

TypeGSKMedical Companies
Consensus Rating Score
2.43
2.68
Consensus RatingHoldModerate Buy
News Sentiment RatingNeutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/9/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 1,950+17.57%
1/31/2024Shore Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
11/28/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingNeutral
11/24/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 1,650+15.71%
10/3/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
9/29/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingUnderweight
9/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetGBX 1,440 ➝ GBX 1,585+3.39%
7/17/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetGBX 1,450 ➝ GBX 1,390+5.22%
6/26/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingHoldGBX 1,575+10.78%
3/6/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Keyur Parekh
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set TargetGBX 2,000+38.68%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:01 AM ET.












GSK Price Target - Frequently Asked Questions

What is GSK's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for GSK stock is Hold based on the current 1 sell rating, 2 hold ratings and 4 buy ratings for GSK. The average twelve-month price prediction for GSK is GBX 1,650 with a high price target of GBX 2,000 and a low price target of GBX 1,300. Learn more on GSK's analyst rating history.

Do Wall Street analysts like GSK more than its competitors?

Analysts like GSK less than other Medical companies. The consensus rating for GSK is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how GSK compares to other companies.

Does GSK's stock price have much upside?

According to analysts, GSK's stock has a predicted upside of 13.26% based on their 12-month stock forecasts.

What analysts cover GSK?

GSK has been rated by Barclays, Berenberg Bank, Citigroup, and Shore Capital in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (LON:GSK) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -